(607) 227-8695info@prendismo.com

David Walt Discusses Challenges In Founding Life Sciences Company

Copyright © Cornell University Play All Videos in Case

Total Case Duration :

  • Date Added : 6/2/2005
  • Clip Duration : 3 min. 17 sec.

Playlists

Please Login to create playlists

David Walt

  • Professor, NCIIA (National Collegiate Inventors and Innovators Alliance)
  • male
  • Caucasian
  • 1952 (Age: 72 years old)
  • Invention to Venture - June 2005 - Session 4 - Entrepreneurs' Perspective
  • Video 1 of 9 in this Case
  • View All Available Videos

Biography

David R. Walt is Robinson Professor of Chemistry at Tufts University. After postdoctoral studies at MIT, he joined the chemistry faculty at Tufts. Professor Walt served as Chemistry Department Chairman from 1989 to 1996. Walt serves on many government advisory panels and boards including service as a member of an NIH study section and he actively participates in government advisory meetings for biodefense. He serves on two National Academy of Sciences National Research Council Committees and previously chaired a National Research Council panel on New Measurement Technologies for the Oceans. In 1999, Walt was Professor Invitee' at Ecole Normale Superieure, Paris.

Walt is the Scientific Founder of Illumina, Inc., a publicly traded, San Diego-based biotechnology company with over 300 employees pursuing next generation genotyping instrumentation. Walt has published over 150 papers, holds over thirty patents, and has given hundreds of invited scientific presentations. Walt's research interests are in the field of sensors with particular focus in the area of fiber-optic chemical sensors. His pioneering research in the field of optical sensors has led to the elucidation of fundamental principles as well as important applications of sensors.

David Walt received a B.S. in Chemistry from the University of Michigan and a Ph.D. in Chemical Biology from SUNY at Stony Brook.

Well in terms of challenges, I think obviously any company is going to have - going to have some challenges. The challenges in terms of starting up Illumina, financial was really not a problem. Identifying the market I think was, because we have the technology platform that was quite broad in terms...(Full transcript available to logged in subscribers.).

Register & Subscribe Login

David Walt videos

Video 1 of 9 Helen Maslocka Shares Background of MedCool, Inc.
  • Invention to Venture - June 2005 - Session 4 - Entrepreneurs' Perspective
  • 6/2/2005
  • Helen Maslocka
  • 2 min. 39 sec.
Video 2 of 9 David Walt Shares Background of Illumina - Growing From Science To Business
  • Invention to Venture - June 2005 - Session 4 - Entrepreneurs' Perspective
  • 6/2/2005
  • David Walt
  • 4 min. 59 sec.
Video 3 of 9 Richard Blumberg Discusses Background of Syntonix and Realization That Medical Discovery Could Become Basis For Company
  • Invention to Venture - June 2005 - Session 4 - Entrepreneurs' Perspective
  • 6/2/2005
  • Richard Blumberg
  • 3 min. 23 sec.
Video 4 of 9 Richard Blumberg States Importance of Partnering With Business and Scientists If You Are To Stay in Academics
  • Invention to Venture - June 2005 - Session 4 - Entrepreneurs' Perspective
  • 6/2/2005
  • Richard Blumberg
  • 3 min. 8 sec.
Video 5 of 9 David Walt Discusses Challenges In Founding Life Sciences Company
  • Invention to Venture - June 2005 - Session 4 - Entrepreneurs' Perspective
  • 6/2/2005
  • David Walt
  • 3 min. 17 sec.
Video 6 of 9 Helen Maslocka States Team is Most Important Asset In Starting Company
  • Invention to Venture - June 2005 - Session 4 - Entrepreneurs' Perspective
  • 6/2/2005
  • Helen Maslocka
  • 2 min. 16 sec.
Video 7 of 9 Helen Maslocka Discusses Importance of Timing of Technology
  • Invention to Venture - June 2005 - Session 4 - Entrepreneurs' Perspective
  • 6/2/2005
  • Helen Maslocka
  • 0 min. 35 sec.
Video 8 of 9 Helen Maslocka Shares Thoughts on Ego and Relationships With Investors, Board and Advisors
  • Invention to Venture - June 2005 - Session 4 - Entrepreneurs' Perspective
  • 6/2/2005
  • Helen Maslocka
  • 3 min. 53 sec.
Video 9 of 9 Richard Blumberg Shares Thoughts on Commercialization of Life Sciences Techniques and Products
  • Invention to Venture - June 2005 - Session 4 - Entrepreneurs' Perspective
  • 6/2/2005
  • Richard Blumberg
  • 3 min. 58 sec.

RELATED VIDEOS

Helen Maslocka Shares Background of MedCool, Inc.
  • Invention to Venture - June 2005 - Session 4 - Entrepreneurs' Perspective
  • 6/2/2005
  • Helen Maslocka
  • 2 min. 39 sec.
David Walt Shares Background of Illumina - Growing From Science To Business
  • Invention to Venture - June 2005 - Session 4 - Entrepreneurs' Perspective
  • 6/2/2005
  • David Walt
  • 4 min. 59 sec.
Richard Blumberg Discusses Background of Syntonix and Realization That Medical Discovery Could Become Basis For Company
  • Invention to Venture - June 2005 - Session 4 - Entrepreneurs' Perspective
  • 6/2/2005
  • Richard Blumberg
  • 3 min. 23 sec.
Richard Blumberg States Importance of Partnering With Business and Scientists If You Are To Stay in Academics
  • Invention to Venture - June 2005 - Session 4 - Entrepreneurs' Perspective
  • 6/2/2005
  • Richard Blumberg
  • 3 min. 8 sec.
David Walt Discusses Challenges In Founding Life Sciences Company
  • Invention to Venture - June 2005 - Session 4 - Entrepreneurs' Perspective
  • 6/2/2005
  • David Walt
  • 3 min. 17 sec.
Helen Maslocka States Team is Most Important Asset In Starting Company
  • Invention to Venture - June 2005 - Session 4 - Entrepreneurs' Perspective
  • 6/2/2005
  • Helen Maslocka
  • 2 min. 16 sec.
Helen Maslocka Discusses Importance of Timing of Technology
  • Invention to Venture - June 2005 - Session 4 - Entrepreneurs' Perspective
  • 6/2/2005
  • Helen Maslocka
  • 0 min. 35 sec.
Richard Blumberg Shares Thoughts on Commercialization of Life Sciences Techniques and Products
  • Invention to Venture - June 2005 - Session 4 - Entrepreneurs' Perspective
  • 6/2/2005
  • Richard Blumberg
  • 3 min. 58 sec.